Redundant role of ASK1-mediated p38MAPK activation in human platelet function

• Published in: Cellular signalling 2020-04, Vol.68, p.109528-109528, Article 109528
• Main Authors: Sledz, Kamila M., Moore, Samantha F., Vijayaragavan, Vijayasameerah, Mallah, Shahida, Goudswaard, Lucy J., Williams, Christopher M., Hunter, Roger W., Hers, Ingeborg
• Format: Article
• Language: English
• Subjects: Animals; Blood Platelets - drug effects; Blood Platelets - enzymology; C-Reactive Protein - metabolism; Collagen - pharmacology; Enzyme Activation - drug effects; Humans; MAP Kinase Kinase Kinase 5 - metabolism; MAP Kinase Signaling System - drug effects; Mice; Models, Biological; p38 Mitogen-Activated Protein Kinases - metabolism; Phospholipases A2 - metabolism; Phosphorylation - drug effects; Platelet Aggregation - drug effects; Platelet Membrane Glycoproteins - metabolism; Thromboxane A2 - metabolism
• ISSN: 0898-6568; 1873-3913
• DOI: 10.1016/j.cellsig.2020.109528

Apoptosis signal-regulating kinase 1 (ASK1) is a member of mitogen-activated protein kinase kinase kinase (MAP3K) family, which recently has been implicated in the regulation of p38 MAPK/PLA2/thromboxane (TxA2) generation, as well as P2Y12 signalling in murine platelets. ASK1 has therefore been proposed as a potential target for anti-thrombotic therapy. At present it is unknown whether ASK1 also contributes to TxA2 formation and platelet function in human. In this study we therefore examined the role of ASK1 using the ASK1 inhibitor selonsertib (GS-4997). We established that ASK1 is responsible for p38 phosphorylation and TxA2 formation in murine platelets, with both GS4997 and p38 inhibitors reducing TxA2 formation. Similar to murine platelets, activation of human platelets resulted in the rapid and transient phosphorylation of ASK1 and the MAP2Ks MMK3/4/6. In contrast, phosphorylation of p38 and its substrate; MAPKAP-kinase2 (MAPKAPK2) was much more sustained. In keeping with these findings, inhibition of ASK1 blocked early, but not later p38/MAPKAPK2 phosphorylation. The latter was dependent on non-canonical autophosphorylation as it was blocked by the p38 inhibitor; SB203580 and the SYK inhibitor; R406. Furthermore, ASK1 and p38 inhibitors had no effect on PLA2 phosphorylation, TxA2 formation and platelet aggregation, demonstrating that this pathway is redundant in human platelets. Together, these results demonstrate that ASK1 contributes to TxA2 formation in murine, but not human platelets and highlight the importance of confirming findings from genetic murine models in humans. •Transgenic studies have shown that ASK1 activates the p38/PLA2/TxA2 pathway in murine platelets.•It is unclear whether this pathway is also important for TxA2 formation in human platelets.•In human platelets, both ASK1-dependent and non-canonical pathways contribute to p38 MAPK activation.•ASK1 activity does not contribute to TxA2 formation and function of human platelets.